European Parliament · 9 July 2020

Draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor

Amendment

Adopted

This was a vote on one amendment to the text, not on the text as a whole.

385 in favour · 254 against · 51 abstained. 690 members voted.

What it asks for, in the Parliament's words

Calls on the Commission to withdraw the approvals for substances if proof or reasonable doubt exists that they will not meet the safety criteria laid down in Regulation (EC) No 1107/2009
Considers that the draft Commission implementing regulation exceeds the implementing powers provided for in Regulation (EC) No 1107/2009
Considers that the draft Commission implementing regulation is not consistent with Union law in that it does not respect the precautionary principle

Quoted from B9-0203/2020, which says more than these lines. Each is a whole paragraph; this site does not rewrite them.